Mail: info@sterilize.it  – Linkedin: sterilize.it


  • Member Area
  • Registration
  • About us
  • Processes
  • Applications
  • Bookstore
  • Useful Links
  • Contact us
  • About us
  • Processes
  • Applications
  • Bookstore
  • Useful Links
  • Contact us

Lowering the risk of personnel induced contamination: The use of robotics in aseptic processing

Abstract

One of the most problematic issues of aseptic manufacturing is the involvement of personnel. Human presence generates millions of particles every minute. Some of these particles are biologically active and can generate product contamination. Now, technology can create a revolution by removing human intervention from the aseptic manufacturing process to reduce its impact on product sterility. Stainless steel GMP robotic arms have been introduced to handle fill finish operations within a gloveless isolator. The advantage of this process, apart from sterility improvement, is the possibility of handling Highly Potent Active Pharmaceutical Ingredients (HPAPIs) like cytotoxic drugs in a flexible and cost-effective way. This article goes through all the main features of the gloveless robotic solution and describes a cluster tool concept for an advanced aseptic production facility.

Introduction

Aside from the usual challenges of traditional blockbuster drugs, on which patents provide a crucial period of exclusivity and protection, the new era of the pharmaceutical industry has been facing expiring patents and a consequent increase in R&D expenditure addressing also a rapidly growing demand for anti-cancer drugs. The largest number of ongoing clinical studies focus on cancer treatments and half of the newly developed anti-cancer  drugs are injectable. Additionally, bio-pharma research is generating new higher value/ lower volume drugs, many of which are highly active. The key drivers for 2020 are related to high value niche therapies and personalized drugs that will require smaller batches, shorter runs, process flexibility and greater process complexity. Increasing quality expectations in this more volatile demand are expected to drive the market towards lower risks, shorter time to market and increased cost-effectiveness.

Since the operator still plays an important role in aseptic manufacturing, glove boxes, isolators and RABS can be considered a simple solution to segregate the processing environment and improve Grade A continuity and SAL (sterility assurance level).

However, the environment is presumed to have a greater chance of actually being sterile if the operator is not present.

[…]

 A courtesy of ‘Clean Air & Containment Review’ – www.cleanairandcontainment.com

  • author: Mauri Sergio

The content you requested is only available for registered users. Please, register to download the file.
It's fast and free. Register here.
If you are a registered user enter your e-mail address and password to log in.

• Download
PDF File

0
0
0
0

related articles

  • History of isolator and containment technology Part 1: Early containment leading to flexible film isolator
  • Aqueous solutions in sealed containers: internal pressure under autoclaving
  • Transient overheating in empty autoclave chambers
  • Product Stability Issues
  • Cycle development: A Practitioner’s Guide

0 Commenti

Leave Reply Annulla risposta

Il tuo indirizzo email non sarà pubblicato. I campi obbligatori sono contrassegnati *

Search
  • Enter your keyword

  • Processes

  • Applications

  • Author

Recent articles
  • A History of Isolator and Containment Technology, Part 5: Development and use of sterilising agents with associated devices
  • A history of isolator and containment technology Part 4: Transfer devices
  • A history of isolator and containment technology Part 3: Non-flexible film isolators including RABS
  • A history of isolator and containment technology Part 2: Flexible film isolators
  • Importance of risk assessment for aseptic transfer in pharmaceutical compounding

Emerging Gloveless Robotic Technologies in Aseptic Manufacturing for Personalized Cytotoxic Drugs

History of isolator and containment technology Part 1: Early containment leading to flexible film isolator

Scroll
Contact

Mail: info@sterilize.it
Linkedin: sterilize.it

Member Area
Accesso
Password persa
Process
  • Aseptic processing
  • Cleaning
  • Chemical bio-decontamination
  • Moist-heat sterilization
  • Sterilization
Application
  • Blood bags
  • Environmental Monitoring
  • Food
  • General
  • Hyaluronic Acid
  • Other applications
  • Package Integrity
  • Pharma – Liquids
  • Pharmaceutical compounding
  • Pre-filled syringes (PFSs)
  • Robotics
  • Sealed containers
  • Validation
Subscribe to newsletter

Subscribe to our newsletter to stay informed about our news and info.

Join here

© Copyright 2020 Sterilize.it. All rights reserved. Privacy Policy e Cookie

Fedegari Autoclavi SpA | Albuzzano - SS 235 Km 8, CAP. 27010 (PV) | REA: PV- 130961 | P.IVA IT00303010185 | PEC: amministrazione@pec.fedegari.com | Capitale Sociale Versato 5.000.000,00 € i.v.